TH Antibodies

Santa Cruz Biotechnology features a diverse variety of TH Antibodies for the detection and analysis of tyrosine hydroxylase, a key enzyme in the biosynthesis of catecholamines. TH Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Tyrosine hydroxylase plays a critical role in the conversion of tyrosine to L-DOPA, the precursor to dopamine, norepinephrine, and epinephrine. The enzyme is essential for neurotransmitter synthesis and is implicated in numerous neurological disorders, making it a significant target for research in neurobiology and pharmacology. Understanding the regulation and function of tyrosine hydroxylase is crucial for developing therapeutic strategies for conditions such as Parkinson's disease and depression. Researchers worldwide rely on TH monoclonal antibodies to advance their understanding of neurotransmitter pathways and cellular signaling mechanisms. The high specificity of TH monoclonal antibodies enables precise detection and quantification of tyrosine hydroxylase in various experimental settings. Investigating tyrosine hydroxylase expression patterns helps reveal important insights about neurological development and disease progression. Santa Cruz Biotechnology monoclonal antibodies for TH detection continue to support breakthrough discoveries in neuroscience research and therapeutic development.